KR20180020664A - 2 component type cosmetic composition - Google Patents
2 component type cosmetic composition Download PDFInfo
- Publication number
- KR20180020664A KR20180020664A KR1020160105360A KR20160105360A KR20180020664A KR 20180020664 A KR20180020664 A KR 20180020664A KR 1020160105360 A KR1020160105360 A KR 1020160105360A KR 20160105360 A KR20160105360 A KR 20160105360A KR 20180020664 A KR20180020664 A KR 20180020664A
- Authority
- KR
- South Korea
- Prior art keywords
- agent
- cps
- carbonate
- viscosity
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 239000002537 cosmetic Substances 0.000 title abstract description 34
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 65
- 239000004480 active ingredient Substances 0.000 claims abstract description 21
- 230000002378 acidificating effect Effects 0.000 claims abstract description 14
- 239000002562 thickening agent Substances 0.000 claims abstract description 11
- 229920000642 polymer Polymers 0.000 claims abstract description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 9
- 229940061720 alpha hydroxy acid Drugs 0.000 claims abstract description 8
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 19
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000001099 ammonium carbonate Substances 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 235000011181 potassium carbonates Nutrition 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 229920001206 natural gum Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- RYJDNPSQBGFFSF-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;carbonic acid Chemical compound OC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RYJDNPSQBGFFSF-WCCKRBBISA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 235000004298 Tamarindus indica Nutrition 0.000 claims description 2
- 240000004584 Tamarindus indica Species 0.000 claims description 2
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 2
- PCMQQJGSGAICNK-UHFFFAOYSA-J [Ca++].[Ca++].OC([O-])=O.OC([O-])=O.[O-]C([O-])=O Chemical compound [Ca++].[Ca++].OC([O-])=O.OC([O-])=O.[O-]C([O-])=O PCMQQJGSGAICNK-UHFFFAOYSA-J 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 2
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 2
- TUCSOESCAKHLJM-UHFFFAOYSA-L dipotassium carbonic acid carbonate Chemical compound [K+].[K+].OC(O)=O.OC(O)=O.[O-]C([O-])=O TUCSOESCAKHLJM-UHFFFAOYSA-L 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 229920000591 gum Polymers 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 2
- XHXKMTAWMZESFU-UHFFFAOYSA-M silver;hydrogen carbonate Chemical compound [Ag+].OC([O-])=O XHXKMTAWMZESFU-UHFFFAOYSA-M 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 claims description 2
- 235000018341 sodium sesquicarbonate Nutrition 0.000 claims description 2
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 claims description 2
- 239000011667 zinc carbonate Substances 0.000 claims description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 2
- 235000004416 zinc carbonate Nutrition 0.000 claims description 2
- 206010040880 Skin irritation Diseases 0.000 abstract description 8
- 230000036556 skin irritation Effects 0.000 abstract description 8
- 231100000475 skin irritation Toxicity 0.000 abstract description 8
- 230000000052 comparative effect Effects 0.000 description 11
- 238000009472 formulation Methods 0.000 description 10
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- -1 ethyl ascorbic acid Chemical compound 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- 235000004433 Simmondsia californica Nutrition 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 229940081733 cetearyl alcohol Drugs 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 230000037384 skin absorption Effects 0.000 description 3
- 231100000274 skin absorption Toxicity 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000221095 Simmondsia Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940083913 c14-22 alcohols Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- JMFWAAWQNCWELL-UHFFFAOYSA-N propan-2-yl hexadecanoate;2-propan-2-ylhexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C.CCCCCCCCCCCCCCC(C(C)C)C(O)=O JMFWAAWQNCWELL-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
본 명세서는 2액형 화장료 조성물에 관하여 기술한다.The present specification describes a two-pack cosmetic composition.
화장료에서 효능을 발휘하기 위해 사용하는 유효성분 중 낮은 pH에서 안정한 성분을 사용하는 경우, 이러한 유효성분을 안정하게 화장료 내에 포함시키기 위한 여러 가지 방법이 고려된다. 화장료에 산성 물질을 포함시켜 화장료의 pH를 낮추는 경우, 피부 사용시 자극 이슈가 발생할 수 있고, 또한 낮은 pH의 화장료에서 점도 유지가 어려울 수 있다. 이에 따라 이러한 유효성분은 가용화 제형으로 사용하는 것이 일반적이며, 적절한 점도를 갖는 제형으로 구현은 어려운 실정이다.When a component stable at low pH is used among the active ingredients used for exerting an effect in a cosmetic, various methods for stably incorporating such an active ingredient into the cosmetic are considered. When the pH of the cosmetic is lowered by incorporating an acidic substance into the cosmetic, problems of irritation may occur when the skin is used, and it may be difficult to maintain the viscosity in a cosmetic having a low pH. Accordingly, such an active ingredient is generally used as a solubilized formulation, and it is difficult to realize a formulation having an appropriate viscosity.
이에, 피부 안전성이 우수하면서, 제형 내에 낮은 pH 에서 안정한 유효성분이 안정적으로 포함될 수 있고, 원하는 점도의 조성물을 구현할 수 있는 조성에 관한 요구가 존재한다.Thus, there is a need for a composition that can stably incorporate an effective ingredient stable at low pH in a formulation while having excellent skin safety, and can realize a composition having a desired viscosity.
일 관점에서, 본 발명이 해결하고자 하는 과제는 저 pH에서 안정한 유효성분을 포함하면서 피부 자극이 없는 안전성이 높은 화장료 조성물을 제공하는 것이다.In view of the above, a problem to be solved by the present invention is to provide a cosmetic composition which contains an active ingredient stable at a low pH and is safe without skin irritation.
다른 관점에서, 본 발명이 해결하고자 하는 과제는 장기 안정성과 고온 안정성이 우수한 화장료 조성물을 제공하는 것이다.In another aspect, a problem to be solved by the present invention is to provide a cosmetic composition excellent in long-term stability and high-temperature stability.
또 다른 관점에서, 본 발명이 해결하고자 하는 과제는 원하는 점도로 구현되는 화장료 조성물을 제공하는 것이다.In another aspect, a problem to be solved by the present invention is to provide a cosmetic composition which is realized with a desired viscosity.
또 다른 관점에서, 본 발명이 해결하고자 하는 과제는 사용감이 우수한 화장료 조성물을 제공하는 것이다.In another aspect, a problem to be solved by the present invention is to provide a cosmetic composition excellent in feeling of use.
또 다른 관점에서, 본 발명이 해결하고자 하는 과제는 피부 흡수력이 향상된 화장료 조성물을 제공하는 것이다.In another aspect, a problem to be solved by the present invention is to provide a cosmetic composition having improved skin absorbency.
또 다른 관점에서, 본 발명이 해결하고자 하는 과제는 저 pH에서 안정한 유효성분을 안정적으로 포함하는 화장료 조성물을 제공하는 것이다.In another aspect, a problem to be solved by the present invention is to provide a cosmetic composition stably containing an active ingredient stable at low pH.
일 관점에서, 본 발명은 산성 폴리머, 알파-하이드록시산 및 유효성분을 포함하는 제1제; 및 탄산염 및 점증제를 포함하는 제2제;를 포함하는 2액형 화장료 조성물에 관한다.In one aspect, the present invention provides a pharmaceutical composition comprising a first agent comprising an acidic polymer, an alpha-hydroxy acid and an active ingredient; And a second agent comprising a carbonate and a thickening agent.
일 관점에서, 본 발명은 저 pH에서 안정한 유효성분을 포함하면서 피부 자극이 없는 안전성이 높은 화장료 조성물을 제공할 수 있다.In one aspect, the present invention can provide a cosmetic composition which contains a stable active ingredient at a low pH and is highly safe without skin irritation.
다른 관점에서, 본 발명은 장기 안정성과 고온 안정성이 우수한 화장료 조성물을 제공할 수 있다.In another aspect, the present invention can provide a cosmetic composition excellent in long-term stability and high-temperature stability.
또 다른 관점에서, 본 발명은 원하는 점도로 구현되는 화장료 조성물을 제공할 수 있다.In yet another aspect, the present invention can provide a cosmetic composition that is implemented with a desired viscosity.
또 다른 관점에서, 본 발명은 사용감이 우수한 화장료 조성물을 제공할 수 있다.From another viewpoint, the present invention can provide a cosmetic composition excellent in feeling of use.
또 다른 관점에서, 본 발명은 피부 흡수력이 향상된 화장료 조성물을 제공할 수 있다.In another aspect, the present invention can provide a cosmetic composition having improved skin absorbency.
또 다른 관점에서, 본 발명은 저 pH에서 안정한 유효성분을 안정적으로 포함하는 화장료 조성물을 제공할 수 있다.In another aspect, the present invention can provide a cosmetic composition stably containing an active ingredient stable at low pH.
도 1은 본 발명 일실시예에 따른 조성물의 제1제의 시간에 따른 점도 변화를 확인한 결과를 나타낸 그래프이다.FIG. 1 is a graph showing a change in viscosity of a first agent of the composition according to an embodiment of the present invention over time. FIG.
이하, 본 발명의 실시예들을 보다 상세하게 설명하고자 한다. 그러나 본 출원에 개시된 기술은 여기서 설명되는 실시예들에 한정되지 않고 다른 형태로 구체화될 수도 있다. 단지, 여기서 소개되는 실시예들은 개시된 내용이 철저하고 완전해질 수 있도록 그리고 당업자에게 본 출원의 사상이 충분히 전달될 수 있도록 하기 위해 제공되는 것이다. 또한, 해당 분야에서 통상의 지식을 가진 자라면 본 출원의 기술적 사상을 벗어나지 않는 범위 내에서 본 출원의 사상을 다양한 다른 형태로 구현할 수 있을 것이다.Hereinafter, embodiments of the present invention will be described in more detail. However, the techniques disclosed in the present application are not limited to the embodiments described herein but may be embodied in other forms. It should be understood, however, that the embodiments disclosed herein are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention.
본 발명 일실시예에 따른 화장료 조성물은 저 pH에서 안정한 유효성분을 제형 내에서 안정하게 포함할 수 있다. 본 실시예에서, 상기 화장료 조성물은 저 pH의 제1제에 상기 유효성분을 포함하고, 제1제와 점도 및 pH가 상이한 제2제를 포함하며, 사용시에 제1제 및 제2제를 혼합하여 사용하므로 보관시 안정성이 우수하며, 사용감 및 피부 안전성이 우수한 화장료 조성물을 제공할 수 있다.The cosmetic composition according to one embodiment of the present invention can stably contain an active ingredient stable at low pH in a formulation. In this embodiment, the cosmetic composition comprises a first agent having a low pH and a second agent containing the active ingredient and having a viscosity and a pH different from that of the first agent, wherein the first agent and the second agent are mixed It is possible to provide a cosmetic composition which is excellent in stability during storage and excellent in use feeling and skin safety.
제1제는 산성 폴리머, 알파-하이드록시산 및 유효성분을 포함할 수 있다.The first agent may comprise an acidic polymer, an alpha-hydroxy acid and an active ingredient.
상기 제1제는 약산성의 pH를 나타내어 유효성분이 안정하게 유지될 수 있으며, 저 pH에서도 경시적으로 점도가 안정하게 유지될 수 있어 제형 안정성이 우수할 수 있다. The first agent exhibits a weakly acidic pH, so that the active ingredient can be stably maintained, and the viscosity can be stably maintained at a low pH over time, so that the formulation stability can be excellent.
상기 제1제는 예를 들어, pH가 3 내지 5일 수 있다.The first agent may, for example, have a pH of from 3 to 5.
상기 제1제는 점도가 예를 들어 20000cps 이상, 21000cps 이상, 22000cps 이상, 23000cps 이상, 또는 24000cps 이상이고, 30000cps 이하, 29000cps 이하, 28000cps 이하, 27000cps 이하, 26000cps 이하, 또는 25000cps 이하일 수 있으며, 예컨대 20000cps 내지 30000cps, 예를 들어 20000cps 내지 25000cps일 수 있으며, 상기 점도 범위 내에서 경시적으로 점도를 유지할 수 있다. 상기와 같은 고점도의 겔 상태인 제1제 내에서 유효성분이 안정하게 유지될 수 있으며, 사용감이 우수한 제형을 구현할 수 있으며, 에어리스 용기에서 배출이 용이할 수 있다.The first agent may have a viscosity of 20000 cps or more, 21000 cps or more, 22000 cps or more, 23000 cps or 24000 cps or more, 30,000 cps or less, 29000 cps or less, 28000 cps or less, 27000 cps or less, 26000 cps or 25000 cps, To 30000 cps, for example, 20000 cps to 25000 cps, and the viscosity can be maintained over time within the viscosity range. The active ingredient can be stably maintained in the first gelatin having the high viscosity as described above, a formulation having excellent feeling of use can be realized, and it can be easily discharged from the airless container.
상기 산성 폴리머는 약산성 조건에서 제형의 점도를 안정하게 유지시킬 수 있으며, 유효성분을 안정적으로 유지시킬 수 있다. 상기 산성 폴리머는 예를 들어 폴리아크릴레이트크로스폴리머-6일 수 있다.The acidic polymer can stably maintain the viscosity of the formulation under a slightly acidic condition and can stably maintain the active ingredient. The acidic polymer may be, for example, polyacrylate crosspolymer-6.
상기 산성 폴리머는 제1제의 총 중량에 대하여, 0.5 중량% 이상, 0.6 중량% 이상, 0.7 중량% 이상, 0.8 중량% 이상, 0.9 중량% 이상, 1 중량% 이상, 1.5 중량% 이상, 2 중량% 이상, 2.5 중량% 이상, 3 중량% 이상, 3.5 중량% 이상, 4 중량% 이상, 4.5 중량% 이상 또는 5 중량% 이상이고, 15 중량% 이하, 14 중량% 이하, 13 중량% 이하, 12 중량% 이하, 11 중량% 이하, 10 중량% 이하, 9 중량% 이하, 8 중량% 이하, 7중량% 이하 또는 6중량% 이하, 예컨대 0.5중량% 내지 15중량%, 예를 들어 1중량% 내지 10중량%로 포함할 수 있다. 상기 범위 내에서 약산성에서 제형의 점도를 안정하게 유지시킬 수 있으며, 유효성분을 안정적으로 포함할 수 있다.Wherein the acidic polymer is present in an amount of at least 0.5 wt%, at least 0.6 wt%, at least 0.7 wt%, at least 0.8 wt%, at least 0.9 wt%, at least 1 wt%, at least 1.5 wt% At least 15 wt.%, At most 14 wt.%, At most 13 wt.%, At least 12 wt.%, At least 2.5 wt.%, At least 3 wt.%, At least 3.5 wt.%, At least 4 wt. Up to 11 wt.%, Up to 9 wt.%, Up to 8 wt.%, Up to 7 wt.% Or up to 6 wt.%, Such as from 0.5 wt.% To 15 wt.%, 10% by weight. Within the above range, the viscosity of the formulation can be stably maintained at a slightly acidic state, and the active ingredient can be stably contained.
상기 알파-하이드록시산은 제1제의 pH를 약산성으로 유지시켜 유효성분을 안정하게 포함시킬 수 있다. 예를들어 말산, 락트산, 글리콜산 및 시트르산 중에서 선택되는 1종 이상일 수 있으나, 이에 제한되지 않는다.The alpha-hydroxy acid can stably contain the active ingredient by keeping the pH of the first agent slightly acidic. For example, it may be at least one selected from malic acid, lactic acid, glycolic acid and citric acid, but is not limited thereto.
상기 알파-하이드록시산은 제1제의 총 중량에 대하여, 0.5 중량% 이상, 0.6 중량% 이상, 0.7 중량% 이상, 0.8 중량% 이상, 0.9 중량% 이상 또는 1 중량% 이상이고, 10 중량% 이하, 9.5 중량% 이하, 9 중량% 이하, 8.5 중량% 이하, 8 중량% 이하, 7.5 중량% 이하, 7중량% 이하, 6.5중량% 이하, 6중량% 이하, 5.5 중량% 이하, 5중량% 이하, 4.5 중량% 이하 또는 4중량% 이하, 예컨대 0.5중량% 내지 10중량%, 예를 들어 1중량% 내지 5중량%로 포함할 수 있다. 상기 범위 내에서 제1제 내에서 유효성분이 안정하게 포함될 수 있다.The alpha-hydroxy acid is present in an amount of at least 0.5 wt%, at least 0.6 wt%, at least 0.7 wt%, at least 0.8 wt%, at least 0.9 wt%, or at least 1 wt% 9.5% or less, 9% or less, 8.5% or less, 8% or less, 7.5% or less, 7% or less, 6.5% or less, 6% or less, 5.5% , 4.5 wt% or less, or 4 wt% or less, such as 0.5 wt% to 10 wt%, such as 1 wt% to 5 wt%. Within this range, the active ingredient can be stably contained in the first agent.
상기 유효성분은 낮은 pH에서 안정한 물질이라면 어느 것이나 사용할 수 있으며, 예를 들어 pH 3 내지 5에서 안정한 물질일 수 있고, 예를 들어 트리소듐 프럭토즈 디포스페이트(trisodium fructose diphosphate), 에틸아스코르브산(ethyl ascorbic acid), 에피갈로카테킨갈레이트(EGCG), 아스코르빌 글루코시드(ascorbyl glucoside) 등일 수 있으나, 이에 제한되지 않는다.The active ingredient may be any substance which is stable at low pH, for example, it may be a stable substance at a pH of 3 to 5, for example, trisodium fructose diphosphate, ethyl ascorbic acid (ethyl but are not limited to, ascorbic acid, epigallocatechin gallate (EGCG), ascorbyl glucoside, and the like.
상기 유효성분은 제1제 총 중량에 대하여 0.05중량% 내지 5중량%, 예를 들어 0.2중량% 내지 2중량%로 포함할 수 있으며, 상기 범위 내에서 효능을 발휘할 수 있으며, 제형 내에서 안정성이 우수할 수 있다.The active ingredient may be contained in an amount of 0.05 to 5% by weight, for example, 0.2 to 2% by weight based on the total weight of the first agent, and may exhibit efficacy within the above range, It can be excellent.
상기 제2제는 탄산염 및 점증제를 포함할 수 있다.The second agent may include a carbonate and a thickener.
상기 제2제는 제1제의 pH를 중화시켜 사용시 피부 자극 문제를 해결할 수 있으며, 제1제와 상이한 점도를 나타내며, 혼합제로서 사용시 점도를 조정할 수 있어 사용감이 우수한 화장료 조성물을 제공할 수 있다.The second agent can neutralize the pH of the first agent to solve the skin irritation problem during use, exhibit a viscosity different from that of the first agent, and can adjust the viscosity when used as a mixed agent, thereby providing a cosmetic composition excellent in feeling of use.
상기 제2제는 약알칼리성을 나타내어 제2제와의 혼합시 중화를 통해 pH를 상승시켜 피부 자극이 없는 안전성 높은 조성물을 제공할 수 있다. 또한 제1제와 혼합시 CO-2가 발생하여 피부 흡수력을 증진시킬 수 있으며, 혼합제의 점도를 저하시켜 점도 조정이 가능하고 부드럽고 산뜻한 사용감을 제공할 수 있다. The second agent exhibits weak alkalinity. When the second agent is mixed with the second agent, the pH is elevated through neutralization to provide a highly safe composition free from skin irritation. Also, when mixed with the first agent, CO- 2 is generated to enhance the skin absorption power, viscosity of the mixture can be lowered, viscosity can be adjusted, and a smooth and refreshing feeling can be provided.
상기 제2제는 예를 들어 pH가 9 내지 10일 수 있다.The second agent may have a pH of, for example, 9 to 10.
상기 제2제는 점도가 예를 들어 10000cps 이상, 11000cps 이상, 12000cps 이상, 13000cps 이상, 14000cps 이상, 15000cps 이상, 16000cps 이상, 17000cps 이상, 또는 18000cps 이상이고, 20000cps 이하, 19000cps 이하, 18000cps 이하, 17000cps 이하, 또는 16000cps이하일 수 있고, 예컨대 10000cps 내지 20000cps, 예를 들어 15000cps 내지 20000cps일 수 있다. 일예에서, 제1제에 비하여 점도가 낮은 제형으로서, 상기 범위 내에서 제형이 안정하며 우수한 사용감을 제공할 수 있고, 에어리스 용기에서 배출이 용이할 수 있다.The second agent preferably has a viscosity of at least 10,000 cps, at least 11,000 cps, at least 12,000 cps, at least 13,000 cps, at least 14,000 cps, at least 15,000 cps, at least 16,000 cps, at least 17,000 cps, at least 18,000 cps, at most 20,000 cps, at most 19,000 cps, at most 18,000 cps, , Or 16000 cps or less, and may be, for example, 10000 cps to 20000 cps, for example, 15000 cps to 20000 cps. In one example, as a formulation having a viscosity lower than that of the first agent, the formulation is stable within the above range and can provide excellent feeling of use and can be easily discharged from an airless container.
상기 탄산염은 제1제의 pH를 중화시키는 역할을 할 수 있으며, 제1제와 혼합시 CO-2가 발생하여 피부 흡수력을 증진시킬 수 있다. 또한 제1제와 혼합시 혼합제의 점도를 저하시켜 부드럽고 산뜻한 사용감을 제공할 수 있다.The carbonate may neutralize the pH of the first agent, and when mixed with the first agent, CO- 2 may be generated to enhance skin absorption. In addition, when mixed with the first agent, the viscosity of the mixed agent is lowered to provide a smooth and refreshing feel.
상기 탄산염은 예컨대 탄산암모늄, 탄산칼륨, 탄산나트륨, 탄산마그네슘, 탄산칼륨, 탄산아연, 이탄산아미노구아니딘, 탄산수소암모늄, 아르기닌바이카보네이트, 실버바이카보네이트, 탄산수소나트륨, 탄산수소칼륨, 세스퀴탄산칼륨, 세스퀴탄산칼슘 및 세스퀴탄산나트륨 중에서 선택되는 1종 이상을 사용할 수 있다.The carbonate may be, for example, ammonium carbonate, potassium carbonate, sodium carbonate, magnesium carbonate, potassium carbonate, zinc carbonate, aminoguanidine peanate, ammonium hydrogen carbonate, arginine bicarbonate, silver bicarbonate, sodium bicarbonate, potassium hydrogen carbonate, potassium sesquicarbonate , Calcium sesquicarbonate, and sodium sesquicarbonate may be used.
상기 탄산염은 제2제의 총 중량에 대하여, 0.1 중량% 이상, 0.2 중량% 이상, 0.3 중량% 이상, 0.4 중량% 이상, 0.5 중량% 이상, 0.6 중량% 이상, 0.7 중량% 이상, 0.8 중량% 이상, 0.9 중량% 이상, 1 중량% 이상, 1.5 중량% 이상, 2 중량% 이상, 2.5 중량% 이상, 3 중량% 이상, 3.5 중량% 이상, 4 중량% 이상, 4.5 중량% 이상 또는 5 중량% 이상이고, 9 중량% 이하, 8.5 중량% 이하, 8 중량% 이하, 7.5 중량% 이하, 7중량% 이하, 6.5중량% 이하, 6중량% 이하, 5.5 중량% 이하, 5중량% 이하, 예컨대 0.1중량% 내지 9중량%, 예를 들어 0.5중량% 내지 6중량%로 포함할 수 있다. 상기 범위 내에서 사용시 피부 자극 없이 안전한 조성물을 제공할 수 있으며, 제1제와 제2제의 혼합제를 혼합하였을 때 CO2 발생을 통하여 피부 흡수력을 증진시킬 수 있다.The carbonate is present in an amount of at least 0.1 wt%, at least 0.2 wt%, at least 0.3 wt%, at least 0.4 wt%, at least 0.5 wt%, at least 0.6 wt%, at least 0.7 wt% , At least 0.9%, at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5% By weight, up to 9% by weight, up to 8.5% by weight, up to 8% by weight, up to 7.5% by weight, up to 7% by weight, up to 6.5% by weight, up to 6% By weight to 9% by weight, for example, 0.5% by weight to 6% by weight. Within this range, it is possible to provide a safe composition without skin irritation when used, and when the first and second additives are mixed, the absorption of the skin through CO 2 generation can be enhanced.
상기 점증제는 제2제를 점증시켜 안정화하며, 적절한 점도를 구현할 수 있다.The thickener gradually increases the stability of the second agent and can achieve an appropriate viscosity.
상기 점증제는 통상적으로 사용되는 점증제를 사용할 수 있으며, 예컨대 로커스트빈검, 아라비아검, 타마린드검, 펙틴, 구아검, 잔탄검 등의 천연 검류, 셀룰로오스검, 카보머, 하이드록시에틸셀룰로오스, 폴리비닐알코올, 피브이피, 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머, 소듐폴리아크릴레이트, 암모늄아크릴로일디메틸타우레이트/브이피코폴리머, 하이드록시프로필스타치포스페이트, 폴리아크릴레이트-13/폴리이소부텐/폴리소르베이트20, 폴리아크릴레이트-13, 하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머, 피이지-240/에이치디아이코폴리머 비스데실테스라세스-2 에틸, 폴리아크릴릭애씨드 등을 사용할 수 있으나 이에 제한되지 않는다. 일예에서, 제2제의 점증제는 고 pH에서의 안정성 및 이취 방지의 관점에서 상기 점증제 중 아미드계, 아민계 또는 암모늄 치환 폴리머를 제외한 점증제를 사용할 수 있다.The thickener may be a commonly used thickener such as natural gums such as locust bean gum, gum arabic, tamarind gum, pectin, guar gum and xanthan gum, cellulose gum, carbomer, hydroxyethyl cellulose, poly Polyvinyl alcohol, polyvinyl acetate, acrylate / C10-30 alkyl acrylate crosspolymer, sodium polyacrylate, ammonium acryloyldimethyltaurate / vpicopolymer, hydroxypropylstarchphosphate, polyacrylate-13 / Polyacrylate-13, hydroxyethylacrylate / sodium acryloyldimethyltaurate copolymer, phage-240 / HCI copolymer bisdecyltestrashe-2-ethyl, polyacrylic acid- But are not limited thereto. In an embodiment, the second thickener may be an enhancer other than the amide-based, amine-based or ammonium-substituted polymer in the above-mentioned increments from the standpoint of stability at high pH and prevention of bad odor.
상기 점증제는 제2제의 총 중량에 대하여, 0.5 중량% 이상, 0.6 중량% 이상, 0.7 중량% 이상, 0.8 중량% 이상, 0.9 중량% 이상 또는 1 중량% 이상이고, 10 중량% 이하, 9.5 중량% 이하, 9 중량% 이하, 8.5 중량% 이하, 8 중량% 이하, 7.5 중량% 이하, 7중량% 이하, 6.5중량% 이하, 6중량% 이하, 5.5 중량% 이하, 5중량% 이하, 4.5 중량% 이하 또는 4중량% 이하, 예컨대 0.5중량% 내지 10중량%, 예를 들어 2중량% 내지 5중량%으로 포함할 수 있다. 상기 범위 내에서 제2제를 안정하게 유지할 수 있으며, 혼합제의 점도 조절이 용이할 수 있다.The agglomerating agent may be present in an amount of 0.5 wt% or more, 0.6 wt% or more, 0.7 wt% or more, 0.8 wt% or more, 0.9 wt% or more or 1 wt% or more, 10 wt% or less, 9.5 wt% Not more than 9 wt%, not more than 8.5 wt%, not more than 8 wt%, not more than 7.5 wt%, not more than 7 wt%, not more than 6.5 wt%, not more than 6 wt%, not more than 5.5 wt% By weight or less, or 4% by weight or less, for example, 0.5% by weight to 10% by weight, for example, 2% by weight to 5% by weight. The second agent can be stably maintained within the above range, and the viscosity of the mixture can be easily controlled.
다른 실시예에서, 상기 제2제는 계면활성제, 오일 및 왁스 중 하나 이상을 더 포함할 수 있다. 상기 오일 및 왁스 중 하나 이상을 더 포함하여 CO2 발생에 의한 가시적 효과를 극대화할 수 있으며, 효능 물질의 차폐 효과를 증진시켜 피부 흡수 증진을 향상시킬 수 있다.In another embodiment, the second agent may further comprise at least one of a surfactant, oil, and wax. The oil and the wax may further include at least one of the oil and the wax to maximize the visible effect due to the generation of CO 2 and improve the shielding effect of the effective substance to improve skin absorption.
상기 계면활성제는 예를 들어 아라키딜알코올/베헤닐알코올/아라키딜글루코사이드(ARACHIDYL ALCOHOL/BEHENYL ALCOHOL/ARACHIDYL GLUCOSIDE), 세테아릴알코올*세테아릴글루코사이드(CETEARYL ALCOHOL*CETEARYL GLUCOSIDE), C14-22알코올*C12-20알킬글루코사이드(C14-22 ALCOHOLS*C12-20 ALKYL GLUCOSIDE), 글리세릴스테아레이트*PEG-100스테아레이트(Glyceryl Stearate*PEG-100 Stearate), sorbitan 계열, glucose 계열, sucrose & 기타 sugar, PEG ester, PEG ether, PEG glycerol ester, PEG-sorbitan, Ionic SAA, 레시틴 계열을 사용할 수 있으나 이에 제한되지 않는다. 상기 계면활성제는 예를 들어 제2제의 총 중량에 대하여 5중량% 내지 10중량%로 포함할 수 있다.The surfactant may be, for example, arachidyl alcohol / behenyl alcohol / arachidyl glucoside, cetearyl alcohol * Cetearyl glucoside, C14-22 alcohol * C12-20 alkyl glucoside (C14-22 ALCOHOLS * C12-20 ALKYL GLUCOSIDE), glyceryl stearate * PEG-100 stearate, sorbitan series, glucose series, sucrose & other sugar, But are not limited to, PEG ester, PEG ether, PEG glycerol ester, PEG-sorbitan, Ionic SAA, lecithin series. The surfactant may include, for example, 5% by weight to 10% by weight based on the total weight of the second agent.
상기 오일 또는 왁스는 예를 들어 천연 오일, 에스테르계 오일, PEG, PPG, 실리콘 오일, 탄화수소계 오일 등을 사용할 수 있으며, 예컨대 호호바씨 오일, 이소프로필팔미테이트, 사이클로펜타실록산*사이클로헥사실록산, 코코-카프릴레이트/카프레이트, 카프릴릭/카프릭트리글리세라이드 등을 사용할 수 있으나 이에 제한되지 않는다. 상기 오일 또는 왁스는 예를 들어 제2제의 총 중량에 대하여 8 내지 15중량%로 포함할 수 있다.The oil or wax may be, for example, natural oil, ester oil, PEG, PPG, silicone oil, hydrocarbon oil and the like, and examples thereof include jojoba seed oil, isopropyl palmitate, cyclopentasiloxane * cyclohexasiloxane, - caprylate / caprate, caprylic / capric triglyceride, and the like. The oil or wax may contain, for example, 8 to 15% by weight based on the total weight of the second agent.
상기 제1제와 제2제는 중량비로 1:5 내지 5:1, 1:3 내지 3:1, 예를 들어 1:1로 포함할 수 있다. 상기 범위 내에서 혼합제의 피부 자극이 없고 안정성이 우수하며, 사용감이 우수한 점도를 제공할 수 있다.The first agent and the second agent may be contained in a weight ratio of 1: 5 to 5: 1, 1: 3 to 3: 1, for example, 1: 1. Within the above range, there is no skin irritation of the mixture, the stability is excellent, and the feeling of use is excellent.
본 발명 실시예들에 따른 화장료 조성물은 사용시에 제1제 및 제2제를 혼합하여 혼합제를 도포하여 사용할 수 있다.In the cosmetic composition according to the embodiments of the present invention, the first agent and the second agent may be mixed and used by applying a mixed agent.
상기 혼합제의 pH는 5 내지 6일 수 있다. 상기 범위 내에서 피부 자극 없이 안전성이 우수할 수 있다.The pH of the mixture may be from 5 to 6. Within this range, safety can be excellent without skin irritation.
상기 혼합제의 점도는 예를 들어 10000cps 이상, 11000cps 이상, 12000cps 이상, 13000cps 이상, 또는 14000cps 이상이고, 15000cps 이하, 14000cps 이하, 13000cps 이하 또는 12000cps 이하일 수 있고, 예컨대 10000cps 내지 15000cps일 수 있다. 혼합제의 점도가 상기와 같이 저하되어 부드럽고 산뜻한 사용감을 제공할 수 있다.The viscosity of the mixture may be, for example, 10000 cps or more, 11000 cps or more, 12000 cps or more, 13000 cps or more, or 14000 cps or more, 15000 cps or less, 14000 cps or less, 13000 cps or 12000 cps or less and 10000 cps to 15000 cps. The viscosity of the mixture is lowered as described above, so that a soft and refreshing feel can be provided.
본 발명 실시예들에 따른 화장료 조성물은 고온 안정성이 우수하여 넓은 온도 범위에서 점도가 일정하게 유지될 수 있다.The cosmetic composition according to the embodiments of the present invention is excellent in high temperature stability and can maintain a constant viscosity over a wide temperature range.
본 발명의 실시예들에 따른 화장료 조성물은 화장품학 또는 피부과학적으로 허용가능한 매질 또는 기제를 함유하여 제형화될 수 있다. 이는 국소적용에 적합한 모든 제형으로서, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀) 및 비이온형의 소낭 분산제의 형태로, 또는 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한 포말(foam)의 형태로 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 사용될 수 있다. 이들 조성물은 당해 분야의 통상적인 방법에 따라 제조될 수 있다.The cosmetic composition according to embodiments of the present invention may be formulated containing a cosmetically or dermatologically acceptable medium or base. It may be in the form of a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome) and a non-ionic follicular dispersion, or a cream, a skin, a lotion, a powder, an ointment, a spray, May be provided in the form of a stick. It can also be used in the form of a foam or in the form of an aerosol composition further containing a compressed propellant. These compositions may be prepared according to conventional methods in the art.
본 발명의 실시예들에 따른 화장료 조성물은 지방 물질, 유기용매, 용해제, 농축제, 겔화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 물, 이온형 또는 비이온형 유화제, 비이온성 에몰리언트, 충전제, 금속이온봉쇄제, 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 상기 보조제는 화장품학 또는 피부과학 분야에서 일반적으로 사용되는 양으로 도입된다.The cosmetic composition according to embodiments of the present invention can be used as a cosmetic composition in the form of a lipid, an organic solvent, a solubilizing agent, a thickening agent, a gelling agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, Such as an emulsifier, a nonionic emollient, a filler, a sequestering agent, a chelating agent, a preservative, a vitamin, a barrier, a wetting agent, a dye, a pigment, a hydrophilic or lipophilic active agent, a lipid vesicle or any other ingredient commonly used in cosmetics May contain adjuvants commonly used in the field of cosmetics or dermatology. Such adjuvants are introduced in amounts commonly used in the cosmetics or dermatological fields.
이하, 실시예, 비교예 및 시험예를 참조하여 본 발명을 상세히 설명한다. 이들은 오로지 본 발명을 보다 구체적으로 설명하기 위해 예시적으로 제시한 것일 뿐, 본 발명의 범위가 이 실시예, 비교예 및 시험예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가지는 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in detail with reference to Examples, Comparative Examples and Test Examples. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not to be construed as limiting the scope of the present invention. It will be self-evident.
[실시예 및 비교예] 2액형 화장료 조성물의 제조[Examples and Comparative Examples] Preparation of two-part cosmetic composition
하기 표 1의 조성에 따라 실시예 1 및 비교예 1의 2액형 화장료 조성물을 제조하였다.Two-part cosmetic compositions of Example 1 and Comparative Example 1 were prepared according to the composition shown in Table 1 below.
[시험예 1] 저 pH에서의 점도 변화 평가[Test Example 1] Evaluation of viscosity change at low pH
상기 실시예 및 비교예 조성물에서, pH가 낮은 제1제의 경시 안정성을 평가하기 위하여 시간에 따른 점도를 측정하여 결과를 도 1에 나타내었다. 점도 측정은 회전식 점성 측정기(Kinexus Ultra+, Malvern Instrument)를 사용하였으며, 점도는 30℃에서 5주간 측정하였다.In order to evaluate the stability with time of the first agent having a low pH in the above Examples and Comparative Examples, the viscosity with time was measured and the results are shown in FIG. The viscosity was measured using a rotary viscometer (Kinexus Ultra +, Malvern Instrument) and the viscosity was measured at 30 ° C for 5 weeks.
도 1의 결과에서, 카보머를 사용한 비교예 1의 경우 시간 변화에 따라 점도 하락이 나타나는 반면, 실시예 1의 조성물의 경우 유의적 점도 변화 없이 일정하게 유지되어 낮은 pH에서도 조성물이 안정하게 유지되는 것을 확인할 수 있다.1, the viscosity of Comparative Example 1 using a carbomer was lowered with time, while the composition of Example 1 was kept constant without significant viscosity change, so that the composition was stably maintained even at a low pH .
[시험예 2] 혼합제의 점도 평가[Test Example 2] Evaluation of viscosity of a mixed material
상기 실시예 및 비교예의 2액형 조성물의 혼합시의 점도 변화를 확인하여 하기 표 3에 나타내었다. 점도 측정은 회전식 점성 측정기(Kinexus Ultra+, Malvern Instrument)를 사용하였으며, 26℃에서 측정하였다.The viscosity changes at the time of mixing the two-pack type compositions of the above Examples and Comparative Examples were confirmed and are shown in Table 3 below. The viscosity was measured using a rotary viscometer (Kinexus Ultra +, Malvern Instrument) at 26 ° C.
표 2의 결과에서, 비교예 1의 경우 혼합제의 점도가 제1제와 제2제의 평균 점도로 비교적 높은 값을 나타내는 반면, 실시예 1의 경우 제1제와 제2제의 점도의 평균값을 밑도는 점도로 점도 저하를 나타내는 것을 확인할 수 있다. From the results of Table 2, it can be seen that the viscosity of the mixture in Comparative Example 1 is relatively high at the average viscosity of the first agent and the second agent, while in the case of Example 1, the average value of the viscosity of the first agent and the second agent is It can be confirmed that the lower viscosity shows a decrease in viscosity.
[시험예 3] 관능평가[Test Example 3] Sensory evaluation
훈련된 전문 패널 8명을 대상으로 실시예와 비교예를 팔 안쪽에 도포하여 사용하여, 혼합 후 피부 도포시 두께감, 밀착감, 부드러움, 수분감, 촉촉함, 잔여감의 6개의 평가 항목을 6항목을 DA (묘사분석 Descriptive analysis)를 통해 분석하였으며, 각각의 강도를 5점 척도(1-매우 나쁨, 5-매우 우수함)로 평가하여 결과를 표 3에 나타내었다.Eight of the trained professional panel were applied to the inside of the arm and the six examples of evaluation items of thickness, adhesion, softness, moisture, moisture, (1 - very poor, 5 - excellent), and the results are shown in Table 3.
표 3의 결과에서 실시예의 조성물이 비교예 조성물에 비하여 두께감, 밀착감, 부드러움, 수분감, 촉촉함, 잔여감의 면에서 현저하게 우수한 사용감을 나타내는 것을 확인할 수 있다.From the results shown in Table 3, it can be confirmed that the compositions of the Examples show significantly better feeling in terms of thickness, adhesion, softness, moisture, moisturization and residual feeling as compared with the compositions of the Comparative Examples.
Claims (18)
탄산염 및 점증제를 포함하는 제2제;를 포함하는 2액형 화장료 조성물.A first agent comprising an acidic polymer, an alpha-hydroxy acid and an active ingredient; And
And a second agent comprising a carbonate and a thickening agent.
상기 제1제는 pH가 3 내지 5인, 조성물.The method according to claim 1,
Wherein the first agent has a pH of from 3 to 5.
상기 제2제는 pH가 9 내지 10인, 조성물.The method according to claim 1,
Wherein the second agent has a pH of 9-10.
상기 제1제는 점도가 20000cps 내지 30000cps인, 조성물.The method according to claim 1,
Wherein the first agent has a viscosity of 20,000 cps to 30,000 cps.
상기 제2제는 점도가 10000cps 내지 20000cps인, 조성물.The method according to claim 1,
Wherein the second agent has a viscosity of from 10,000 cps to 20,000 cps.
상기 산성 폴리머는 폴리아크릴레이트크로스폴리머-6인, 조성물.The method according to claim 1,
Wherein the acidic polymer is polyacrylate crosspolymer-6.
상기 점증제는 천연 검류를 포함하는, 조성물.The method according to claim 1,
Wherein the thickener comprises a natural gum.
상기 천연 검류는 로커스트빈검, 아라비아검, 타마린드검, 펙틴, 구아검 및 잔탄검 중에서 선택되는 것인, 조성물.8. The method of claim 7,
Wherein the natural gums are selected from locust bean gum, gum arabic, tamarind gum, pectin, guar gum and xanthan gum.
상기 알파-하이드록시산은 말산, 락트산, 글리콜산 및 시트르산 중에서 선택되는 것인, 조성물.The method according to claim 1,
Wherein the alpha-hydroxy acid is selected from malic acid, lactic acid, glycolic acid and citric acid.
상기 탄산염은 탄산암모늄, 탄산칼륨, 탄산나트륨, 탄산마그네슘, 탄산칼륨, 탄산아연, 이탄산아미노구아니딘, 탄산수소암모늄, 아르기닌바이카보네이트, 실버바이카보네이트, 탄산수소나트륨, 탄산수소칼륨, 세스퀴탄산칼륨, 세스퀴탄산칼슘 및 세스퀴탄산나트륨 중에서 선택되는 것인, 조성물.The method according to claim 1,
The carbonate may be selected from the group consisting of ammonium carbonate, potassium carbonate, sodium carbonate, magnesium carbonate, potassium carbonate, zinc carbonate, aminoguanidine peanate, ammonium bicarbonate, arginine bicarbonate, silver bicarbonate, sodium bicarbonate, potassium hydrogen carbonate, potassium sesquicarbonate, Calcium sesquicarbonate and sodium sesquicarbonate.
상기 제1제 및 제2제를 혼합한 혼합제의 pH는 5 내지 6인, 조성물.The method according to claim 1,
Wherein the pH of the mixture of the first and second agents is 5 to 6.
상기 제1제 및 제2제를 혼합한 혼합제의 점도는 10000cps 내지 15000cps인, 조성물.The method according to claim 1,
Wherein the viscosity of the mixture of the first and second agents is from 10000 cps to 15000 cps.
상기 제1제와 제2제는 중량비로 1:5 내지 5:1의 비율로 포함하는, 조성물.The method according to claim 1,
Wherein the first and second agents are present in a weight ratio of 1: 5 to 5: 1.
상기 산성 폴리머는 상기 제1제의 총 중량에 대하여 1중량% 내지 10중량%로 포함하는, 조성물.The method according to claim 1,
Wherein the acidic polymer comprises from 1% to 10% by weight relative to the total weight of the first agent.
상기 알파-하이드록시산은 상기 제1제의 총 중량에 대하여 1중량% 내지 5중량%로 포함하는, 조성물.The method according to claim 1,
Wherein the alpha-hydroxy acid comprises from 1 wt% to 5 wt%, based on the total weight of the first agent.
상기 탄산염은 상기 제2제의 총 중량에 대하여 0.5중량% 내지 6중량%로 포함하는, 조성물.The method according to claim 1,
Wherein the carbonate comprises from 0.5% to 6% by weight based on the total weight of the second agent.
상기 점증제는 상기 제2제의 총 중량에 대하여 2중량% 내지 5중량%로 포함하는, 조성물.The method according to claim 1,
Wherein the thickener comprises from 2% to 5% by weight based on the total weight of the second agent.
상기 제2제는 계면활성제, 오일 및 왁스 중 하나 이상을 더 포함하는, 조성물.The method according to claim 1,
Wherein the second agent further comprises at least one of a surfactant, an oil, and a wax.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160105360A KR102692716B1 (en) | 2016-08-19 | 2016-08-19 | 2 component type cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160105360A KR102692716B1 (en) | 2016-08-19 | 2016-08-19 | 2 component type cosmetic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180020664A true KR20180020664A (en) | 2018-02-28 |
KR102692716B1 KR102692716B1 (en) | 2024-08-08 |
Family
ID=61401360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160105360A KR102692716B1 (en) | 2016-08-19 | 2016-08-19 | 2 component type cosmetic composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102692716B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102092728B1 (en) * | 2018-12-04 | 2020-03-24 | 아이큐어 주식회사 | Two part cosmetic composition, Cosmetics containing the same and manufacturing method thereof |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010031864A (en) | 1997-11-07 | 2001-04-16 | 추후보정 | Viscous Compositions Containing Carbon Dioxide |
KR20110118066A (en) * | 2010-09-15 | 2011-10-28 | 그린텍이십일 주식회사 | Cosmetic composition containing an acidic polymer and a carbonate to generate carbon dioxide |
JP2013508310A (en) * | 2009-10-29 | 2013-03-07 | ザ プロクター アンド ギャンブル カンパニー | Transparent cosmetic composition |
KR20140054576A (en) * | 2012-10-29 | 2014-05-09 | 코웨이 주식회사 | Low viscosity cosmetic composition having luxurious appearance |
-
2016
- 2016-08-19 KR KR1020160105360A patent/KR102692716B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010031864A (en) | 1997-11-07 | 2001-04-16 | 추후보정 | Viscous Compositions Containing Carbon Dioxide |
JP2013508310A (en) * | 2009-10-29 | 2013-03-07 | ザ プロクター アンド ギャンブル カンパニー | Transparent cosmetic composition |
KR20110118066A (en) * | 2010-09-15 | 2011-10-28 | 그린텍이십일 주식회사 | Cosmetic composition containing an acidic polymer and a carbonate to generate carbon dioxide |
KR20140054576A (en) * | 2012-10-29 | 2014-05-09 | 코웨이 주식회사 | Low viscosity cosmetic composition having luxurious appearance |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
KR102092728B1 (en) * | 2018-12-04 | 2020-03-24 | 아이큐어 주식회사 | Two part cosmetic composition, Cosmetics containing the same and manufacturing method thereof |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11911498B2 (en) | 2020-06-01 | 2024-02-27 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Also Published As
Publication number | Publication date |
---|---|
KR102692716B1 (en) | 2024-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10588858B2 (en) | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof | |
US11219631B2 (en) | Foamable compositions, breakable foams and their uses | |
US10350166B2 (en) | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses | |
KR20180020664A (en) | 2 component type cosmetic composition | |
KR20070068288A (en) | Hair growth stimulating composition | |
KR20170033483A (en) | Natural surfactant for cosmetics and cosmetic composition comprising the same | |
KR101621942B1 (en) | Cosmetic composition designed for improved topical delivery of effective compounds | |
KR20190001136A (en) | Composition of face-lifting pack for improving skin condition comprising oligopeptides | |
KR102453890B1 (en) | A composition for stabilizing component with ph sensitivity | |
KR20110055051A (en) | Cosmetic composition with low viscosity | |
KR20180057712A (en) | Non-rinse chemical foams containing brimonidine, and uses thereof in the treatment of laundromat | |
KR102432885B1 (en) | Cosmetic composition for anti-aging | |
KR20140094187A (en) | Surfactant-free self-foaming cosmetic composition | |
KR102211754B1 (en) | Elongational cosmetic composition with shape restoration ability and manufacturing method thereof | |
KR102485847B1 (en) | A cosmetic composition capable of changing the shape from an emulsified cream state to a mist state | |
KR20220148632A (en) | High hardness liquid crystal cosmetic composition with bouncy texture and manufacturing method thereof | |
KR20090014413A (en) | Cosmetic composition for skin miosture | |
KR20220057362A (en) | Cosmetic composition with improved spraying power | |
KR20180059532A (en) | Non-rinsing chemical foams containing ivermectin | |
KR20180036110A (en) | A cosmetic composition for enhancing elasticity | |
JPH11322539A (en) | Transparent cosmetic material for body | |
KR20040056336A (en) | Non water-soluble whitening makeup composition and method for preparing therof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |